Literature DB >> 32143076

Differential mechanisms regarding triclosan vs. bisphenol A and fluorene-9-bisphenol induced zebrafish lipid-metabolism disorders by RNA-Seq.

Limei Sun1, Yuhang Ling1, Jiahui Jiang1, Danting Wang1, Junxia Wang2, Jieyi Li2, Xuedong Wang3, Huili Wang4.   

Abstract

Exposure of endocrine disrupting chemicals (EDCs) is closely related to induction of obesity, nonalcoholic fatty liver disease (NAFLD) and other lipid-metabolism diseases. Herein, we compared the effects of three EDCs exposure (triclosan, bisphenol A and fluorene-9-bisphenol) on lipid metabolism in zebrfish (Danio rerio). The differential lipid-metabolism disorders were analyzed in depth through RNA-Seq and qRT-PCR, as well as assessment of the relationship between lipid disorder and RNA methylation. Histopathological observation along with varying physiological and biochemical indexes all identified that triclosan and bisphenol A induced liver fat accumulation in acute and chronic exposure. RNA-Seq analysis showed that triclosan exposure disrupted multiple physiological processes including drug metabolism, sucrose metabolism, fat metabolism and bile secretion. The dysregulation of lipid-metabolism related genes indicated that liver steatosis in triclosan and BPA-exposed zebrafish resulted from increased fatty acid synthetase, and uptake and suppression of β-oxidation. Besides, the dysregulation of pro-inflammatory genes and endoplasmic reticulum stress showed that triclosan and bisphenol A exposure not only induced occurrence of NAFLD, but also promoted progression of hepatic inflammation. However, no significant effect on lipid metabolism was observed in fluorene-9-bisphenol-exposed treatment although the larval phenotypic malformation was found compared to the control group. Moreover, EDCs exposure led to decreased global m6A level and abnormal expression of m6A modulators in larvae. Especially, the expression of demethylase FTO (fat mass and obesity-associated protein) was significantly increased in triclosan-exposure treatment. These findings are conductive for us to deeply understand the underlying molecular mechanisms regarding the obesity and NAFLD from EDCs exposure.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bisphenol A; Lipid-metabolism disorder; Transcriptome sequencing; Triclosan; m(6)A RNA methylation

Mesh:

Substances:

Year:  2020        PMID: 32143076     DOI: 10.1016/j.chemosphere.2020.126318

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  7 in total

Review 1.  Obesity II: Establishing causal links between chemical exposures and obesity.

Authors:  Jerrold J Heindel; Sarah Howard; Keren Agay-Shay; Juan P Arrebola; Karine Audouze; Patrick J Babin; Robert Barouki; Amita Bansal; Etienne Blanc; Matthew C Cave; Saurabh Chatterjee; Nicolas Chevalier; Mahua Choudhury; David Collier; Lisa Connolly; Xavier Coumoul; Gabriella Garruti; Michael Gilbertson; Lori A Hoepner; Alison C Holloway; George Howell; Christopher D Kassotis; Mathew K Kay; Min Ji Kim; Dominique Lagadic-Gossmann; Sophie Langouet; Antoine Legrand; Zhuorui Li; Helene Le Mentec; Lars Lind; P Monica Lind; Robert H Lustig; Corinne Martin-Chouly; Vesna Munic Kos; Normand Podechard; Troy A Roepke; Robert M Sargis; Anne Starling; Craig R Tomlinson; Charbel Touma; Jan Vondracek; Frederick Vom Saal; Bruce Blumberg
Journal:  Biochem Pharmacol       Date:  2022-04-05       Impact factor: 6.100

Review 2.  Obesity III: Obesogen assays: Limitations, strengths, and new directions.

Authors:  Christopher D Kassotis; Frederick S Vom Saal; Patrick J Babin; Dominique Lagadic-Gossmann; Helene Le Mentec; Bruce Blumberg; Nicole Mohajer; Antoine Legrand; Vesna Munic Kos; Corinne Martin-Chouly; Normand Podechard; Sophie Langouët; Charbel Touma; Robert Barouki; Min Ji Kim; Karine Audouze; Mahua Choudhury; Nitya Shree; Amita Bansal; Sarah Howard; Jerrold J Heindel
Journal:  Biochem Pharmacol       Date:  2022-04-05       Impact factor: 6.100

3.  Comparison of Transcriptomics Changes Induced by TCS and MTCS Exposure in Human Hepatoma HepG2 Cells.

Authors:  Xiaoqian Li; Yu Shang; Weiwei Yao; Yi Li; Ning Tang; Jing An; Yongjie Wei
Journal:  ACS Omega       Date:  2020-05-06

4.  Emerging concepts and opportunities for endocrine disruptor screening of the non-EATS modalities.

Authors:  Christopher J Martyniuk; Rubén Martínez; Laia Navarro-Martín; Jorke H Kamstra; Adam Schwendt; Stéphane Reynaud; Lorraine Chalifour
Journal:  Environ Res       Date:  2021-08-19       Impact factor: 6.498

Review 5.  The role of RNA m6A methylation in lipid metabolism.

Authors:  Yuting Wang; Yujie Wang; Jiarui Gu; Tianhong Su; Xiaosong Gu; Yu Feng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-08       Impact factor: 6.055

6.  Occurrence of multiclass endocrine disrupting compounds in a drinking water supply system and associated risks.

Authors:  Sze Yee Wee; Ahmad Zaharin Aris; Fatimah Md Yusoff; Sarva Mangala Praveena
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

7.  Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology.

Authors:  Emir Malovic; Alyssa Ealy; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Toxicol Sci       Date:  2021-04-27       Impact factor: 4.109

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.